Background illustration for clinical trials search

Paid Clinical Trials Lexington

Discover 419 paid clinical trials in Lexington, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Lexington KY, Louisville KY, Cincinnati OH,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase2, Phase3, Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,
Location: Lexington KY, Cincinnati OH, Huntington WV,
Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase2, Recruiting

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

for
Cervical Cancer, Breast Cancer, Colon Cancer, NSCLC,
Location: Lexington KY, Glen Burnie MD, Omaha NE
Sponsor: Orano Med Theranostics, SAS

Sex: All

Age: 18+

Code: NCT05283330

Phase1, Recruiting

A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

for
Primary Generalized Tonic-Clonic Seizures
Location: Lexington KY, Columbus OH, Akron OH, Winston-Salem NC,
Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 12+

Code: NCT05667142

Phase3, Recruiting

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

for
Focal Epilepsy
Location: Lexington KY, Cincinnati OH, Columbus OH, Nashville TN,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06132893

Phase2, Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Imatinib TDM in GIST

for
Gastrointestinal Stromal Tumors
Location: Lexington KY
Sponsor: Reema A. Patel

Sex: All

Age: 18+

Code: NCT05493215

Phase2, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Louisville KY, Columbus OH, Nashville TN, Cleveland OH,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase1, Recruiting

Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

for
Metastatic Melanoma, BRAF Gene Mutation
Location: Lexington KY, Nashville TN, Easton PA
Sponsor: Rina Plattner

Sex: All

Age: 18+

Code: NCT04903119

Phase1, Recruiting

Precision Lung Cancer Survivorship Care Intervention

for
Lung Cancer, Pulmonary Neoplasm, Neoplasms, Lung,
Location: Lexington KY
Sponsor: Jerod L Stapleton, PhD

Sex: All

Age: 18+

Code: NCT05857995

Recruiting

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

for
Advanced Malignant Solid Neoplasm,
Location: Lexington KY, Columbus OH, Nashville TN, Chicago IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06311214

Phase2, Recruiting

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Lexington KY, Shiloh IL, Pittsburgh PA, Chicago IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05896839

Phase1, Phase2, Recruiting

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

for
Metastatic Colorectal Carcinoma,
Location: Lexington KY, Indianapolis IN, Columbus OH, Carmel IN,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT05863195

Phase3, Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Lexington KY, Cincinnati OH, Knoxville TN, Columbus OH,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase3, Recruiting

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

for
Carcinoma, Squamous Cell
Location: Lexington KY, Cincinnati OH, Charlotte NC, Atlanta GA,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All

Age: 60+

Code: NCT04892173

Phase3, Recruiting

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

for
Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation,
Location: Lexington KY, Columbus OH, Winston-Salem NC, Chicago IL,
Sponsor: National Cancer Institute (NCI)

Sex: Male

Age: 18+

Code: NCT05691465

Phase2, Recruiting

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Lexington KY, Nashville TN, Chicago IL, Durham NC,
Sponsor: Clasp Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06778863

Phase1, Recruiting

Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial

for
Advanced Malignant Solid Neoplasm,
Location: Lexington KY, Atlanta GA, Pittsburgh PA, Chicago IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05327010

Phase2, Recruiting

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

for
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma,
Location: Lexington KY, Louisville KY, Cincinnati OH,
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04637763

Phase1, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Lexington KY, Louisville KY, Cincinnati OH, Dayton OH,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase3, Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Lexington KY, Jeffersonville IN, Cincinnati OH,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06510374

Phase3, Recruiting